SPT group (n=9) IPT group (n=51) IPT group (n=51) P-value
Monitoring period (months) Monitoring period (months) Monitoring period (months) 13.8 ± 6.9 7.0 ± 5.7 7.0 ± 5.7 0.009*
Age (years) Age (years) Age (years) 89.1 ± 4.4 85.9 ± 7.6 85.9 ± 7.6 0.303
Sex: Female, n (%) Sex: Female, n (%) Sex: Female, n (%) 5 (56%) 27 (53%) 27 (53%) 1.000
BMI (kg/m2) BMI (kg/m2) BMI (kg/m2) 20.0 ± 3.8 21.9 ± 3.5 21.9 ± 3.5 0.125
Indication for implantation Indication for implantation Indication for implantation Indication for implantation Indication for implantation Indication for implantation Indication for implantation
SSS, n (%) SSS, n (%) 2 (22%) 12 (24%) 12 (24%) 0.482
CAVB, n (%) CAVB, n (%) 5 (56%) 32 (63%) 32 (63%)
Type II AVB, n (%) Type II AVB, n (%) 0 3 (6%) 3 (6%)
AF bradycardia, n (%) AF bradycardia, n (%) 2 (22%) 4 (7%) 4 (7%)
Underlying disease Underlying disease Underlying disease Underlying disease Underlying disease Underlying disease Underlying disease
IHD 1 (11%) 2 (4%) 2 (4%) 0.056
Valvular disease 3 (33%) 11 (22%) 11 (22%)
Cardiomyopathy 1 (11%) 0 0
Others 4 (44%) 38 (74%) 38 (74%)
BNP BNP BNP 707 ± 729 434 ± 427 434 ± 427 0.382
LVEF LVEF LVEF 57.2 ± 11.2 57.2 ± 11.2 59.8 ± 7.4 0.477
HT, n (%) HT, n (%) HT, n (%) 5 (56%) 5 (56%) 28 (56%) 1.000
DM, n (%) DM, n (%) DM, n (%) 4 (44%) 4 (44%) 11 (23%) 0.218
HD, n (%) HD, n (%) HD, n (%) 0 (0%) 0 (0%) 1 (2%) 1.000